Filing Flows › Apnimed (APMD) › Recalls, complaints & regulation
Apnimed (APMD): clinical trials
Apnimed (APMD) beyond its filings: 1 active clinical trial.
Apnimed's latest quarter
Apnimed, Q2 2026: revenue $12.1M (-29% year over year), operating margin -96.9%, net earnings $126M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Apnimed have?
1 active study on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.